Author

Claudia Fischer

University of BaselPrimary ORCID profile (0009-0002-3266-9641 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Claudia FischeriD2 papers · University of Basel

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Andreas Zingg· 1 shared Christoph SchultheißiD· 1 shared Heinz Philipp LaubliiD· 1 shared Mascha BinderiD· 1 shared Natascha Franz· 1 shared Paul Schmidt-BarboiD· 1 shared Sarah AdamoiD· 1 shared Simon StücheliiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andreas Zingg

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CAR T cell engineering impacts antigen-independent activation and co-inhibition

Simon Stücheli, Christoph Schultheiß, Paul Schmidt-Barbo, Andreas Zingg, Natascha Franz, Sarah Adamo, Claudia Fischer, Heinz Philipp Laubli, Mascha Binder

This study compares viral and non-viral methods for CAR T cell engineering, finding that non-viral SB transposition alters T cell activation and co-inhibition markers, with CAR design and donor type influencing outcomes.

bioRxiv · Jan 20, 2025 · PreprintImmunology